Avandia Maker Sets Aside $3.4 Billion for Lawsuits

British drug manufacturer GlaxoSmithKline (GSK), which makes the recalled diabetes drug Avandia, has set aside a $3.4 billion "to pay for United States government investigations and product liability cases over its marketing of" Avandia. Click here to read the entire New York Times article. This set aside is in addition to the $2.36 billion charge [...]